Coyle Kathryn, Singh Prashant Kumar, Kaushik Ravi, Huque Rumana, Khan Zohaib, Mehrotra Ravi, Siddiqi Kamran, Pokhrel Subhash
Health Economics Research Group (HERG), Department of Health Sciences, Brunel University London, Uxbridge, UK.
Division of Preventive Oncology and Population Health, ICMR-National Institute of Cancer Prevention and Research, Noida, India.
Nicotine Tob Res. 2025 Mar 24;27(4):684-692. doi: 10.1093/ntr/ntae067.
Under the current policy landscapes, the lifetime health and economic burden of smokeless tobacco (ST) products, consumed by over 297 million ST users in South Asia, is unknown. The aim of this study was to estimate the lifetime health effects and costs attributable to current and future ST use in Bangladesh, India, and Pakistan where the majority of ST users live.
We developed a Markov-based state-transition model (ASTRAMOD) to predict the lifetime costs of treatment of four diseases (oral, pharyngeal, esophageal cancers, and stroke) and disability-adjusted life years (DALYs), attributable to the current and future use of ST under existing ST policy scenario. Country-specific Global Adult Tobacco Surveys, life tables, and meta-analyses of South Asian and South East Asian studies were used to populate the model. A probabilistic sensitivity analysis evaluated the uncertainty in model predictions.
If there were no change in the current ST policies, the lifetime ST-attributable treatment costs would be over US$19 billion in India, over US$1.5 billion in Bangladesh, and over US$3 billion in Pakistan. For all countries, the attributable costs are higher for younger cohorts with costs declining with increasing age for those over 50. The model predicted that a typical 15-year-old male adoloscent would gain 0.07-0.18 life years, avert 0.07-0.19 DALYs, and generate a cost-savings of US$7-21 on healthcare spending if ST policies were changed to eliminate ST use.
Policy interventions aimed at decreasing the uptake of ST and increasing quitting success have the potential to substantially decrease the economic and health burden of ST.
This study provides the most comprehensive estimates of the lifetime health and economic burden of ST by 5-year age and sex cohorts. This is also the first study that highlights the scale of health and economic burden of ST in Bangladesh, India, and Pakistan if there were no changes in the current ST policies. Policymakers and practitioners can use the reported data to justify their decisions to improve current ST policies and practices in their country. Researchers can use the ASTRAMOD methodology to estimate the impact of future ST policy changes.
在当前政策环境下,南亚超过2.97亿无烟烟草(ST)使用者所面临的终生健康和经济负担尚不清楚。本研究的目的是估计孟加拉国、印度和巴基斯坦(大多数ST使用者所在国家)当前和未来使用ST所导致的终生健康影响和成本。
我们开发了一个基于马尔可夫的状态转换模型(ASTRAMOD),以预测在现有ST政策情景下,当前和未来使用ST导致的四种疾病(口腔癌、咽癌、食管癌和中风)的终生治疗成本以及伤残调整生命年(DALYs)。使用特定国家的全球成人烟草调查、生命表以及南亚和东南亚研究的荟萃分析来填充模型。概率敏感性分析评估了模型预测中的不确定性。
如果当前ST政策不变,印度因ST导致的终生治疗成本将超过190亿美元,孟加拉国超过15亿美元,巴基斯坦超过30亿美元。对于所有国家,年轻人群的归因成本更高,50岁以上人群的成本随年龄增长而下降。该模型预测,如果改变ST政策以消除ST使用,一名典型的15岁男性青少年将获得0.07 - 0.18个生命年,避免0.07 - 0.19个DALYs,并在医疗支出上节省7 - 21美元。
旨在减少ST使用和提高戒烟成功率的政策干预措施有可能大幅降低ST的经济和健康负担。
本研究提供了按5岁年龄和性别队列划分的ST终生健康和经济负担的最全面估计。这也是第一项强调如果当前ST政策不变,孟加拉国、印度和巴基斯坦ST的健康和经济负担规模的研究。政策制定者和从业者可以使用报告的数据来证明他们改进本国当前ST政策和做法的决策是合理的。研究人员可以使用ASTRAMOD方法来估计未来ST政策变化的影响。